ResMed closes $225m Propeller Health purchase

ResMed (NYSE:RMD) said yesterday that it completed its $225 million acquisition of Propeller Health and its digital medicine platform.
Lead by CEO David Van Sickle, Propeller will continue to operate as a standalone business within ResMed’s respiratory care portfolio, the companies reported.
Get the full story at our sister site, Drug Delivery Business News.
The post ResMed closes $225m Propeller Health purchase appeared first on MassDevice.

Source: Mass Device - January 8, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Featured Mergers & Acquisitions Pharmaceuticals Respiratory Wall Street Beat Propeller Health ResMed Inc. Source Type: news